Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Top Cited Papers
Open Access
- 1 September 2016
- journal article
- research article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 80 (6), 424-431
- https://doi.org/10.1016/j.biopsych.2015.10.018
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety OutcomesPLoS Medicine, 2013
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major DepressionBiological Psychiatry, 2012
- Ketamine for Treatment-Resistant Unipolar DepressionCNS Drugs, 2012
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled StudyNeuropsychopharmacology, 2012
- Ketamine as a Novel Antidepressant: From Synapse to BehaviorCancer Cell, 2011
- Grand challenges in global mental healthNature, 2011
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive DisorderThe Journal of Clinical Psychiatry, 2010
- Consequences of chronic ketamine self‐administration upon neurocognitive function and psychological wellbeing: a 1‐year longitudinal studyAddiction, 2009
- The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluationPsychological Medicine, 2004
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979